EUVIMEDEUVIMED entdecken
Multizentrische Studie

Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry

Yukihiro Watanabe, Yoshiaki Kubota, Hiroshige Murata, Saori Uchiyama, Kuniya Asai, Takahito Nasu, Shunsuke Ishii, Nobuyuki Kagiyama, Keisuke Kida, Wataru Fujimoto, Atsushi Kikuchi, Takeshi Ijichi und 3 weitere

International Heart Journal · 30.05.2026 · 67 (3) · 221-227

DOI: 10.1536/ihj.25-686 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Heart Journal, erschienen am 30.05.2026. Verfasst von Yukihiro Watanabe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Nippon Medical School. Hauptthemen laut MEDLINE: Aminobutyrates, Amyloid Neuropathies, Familial, Angiotensin Receptor Antagonists, Cardiomyopathies. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminobutyratesAmyloid Neuropathies, FamilialAngiotensin Receptor AntagonistsCardiomyopathiesHeart FailureTetrazolesValsartanAgedAged, 80 and overFemaleHumansMaleBiphenyl CompoundsDrug CombinationsHyperkalemiaHypotensionJapanRegistriesRetrospective Studies

Stichwörter der Autor:innen

AmyloidosisAngiotensin receptor-neprilysin inhibitorHeart failure

Substanzen

AminobutyratesAngiotensin Receptor AntagonistsBiphenyl CompoundsDrug Combinationssacubitril and valsartan sodium hydrate drug combinationTetrazolesValsartan

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Nippon Medical School.
  • Division of Cardiovascular Intensive Care, Nippon Medical School Hospital.
  • Division of Cardiology, Department of Internal Medicine, Iwate Medical University.
  • Department of Cardiovascular Medicine, Kitasato University School of Medicine.
  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine.
  • Department of Digital Health and Telemedicine, R&D.

Zitieren

APA

Watanabe, Y., Kubota, Y., Murata, H., Uchiyama, S., Asai, K., Nasu, T., Ishii, S., Kagiyama, N., Kida, K., Fujimoto, W., Kikuchi, A., Ijichi, T., Shibata, T., Kanaoka, K., & Matsumoto, S. (2026). Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry. International Heart Journal, 67(3), 221-227. https://doi.org/10.1536/ihj.25-686

Vancouver

Watanabe Y, Kubota Y, Murata H, Uchiyama S, Asai K, Nasu T, et al. Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry. International Heart Journal. 2026;67(3):221-227. doi:10.1536/ihj.25-686

BibTeX
@article{Watanabe2026,
  author = {Watanabe, Yukihiro and Kubota, Yoshiaki and Murata, Hiroshige and Uchiyama, Saori and Asai, Kuniya and Nasu, Takahito and Ishii, Shunsuke and Kagiyama, Nobuyuki and Kida, Keisuke and Fujimoto, Wataru and Kikuchi, Atsushi and Ijichi, Takeshi and Shibata, Tatsuhiro and Kanaoka, Koshiro and Matsumoto, Shingo},
  title = {Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry},
  journal = {International Heart Journal},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {221--227},
  doi = {10.1536/ihj.25-686}
}
Kostenlos starten →